EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Eur J Cardiothorac Surg 2008;34:365-369. doi:10.1016/j.ejcts.2008.05.010
Copyright © 2008, European Association for Cardio-thoracic Surgery. Published by Elsevier. All rights reserved.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Grzegorz Suwalski
Piotr Suwalski
Krzysztof J. Filipiak
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suwalski, G.
Right arrow Articles by Opolski, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Suwalski, G.
Right arrow Articles by Opolski, G.
Related Collections
Right arrow Cardiac - pharmacology
Right arrow Coronary disease

The effect of off-pump coronary artery bypass grafting on platelet activation in patients on aspirin therapy until surgery day

Grzegorz Suwalskia,*, Piotr Suwalskia, Krzysztof J. Filipiakb, Marek Postulab,c, Franciszek Majstraka, Grzegorz Opolskib

a Department of Cardiac Surgery, Ist Chair of Cardiology, Medical University of Warsaw, Banacha 1 a Street, 02-097 Warsaw, Poland
b Department of Cardiology, Ist Chair of Cardiology, Medical University of Warsaw, Warsaw, Poland
c Department of Experimental and Clinical Pharmacotherapy, Medical University of Warsaw, Warsaw, Poland

Received 14 November 2007; received in revised form 28 April 2008; accepted 7 May 2008.

* Corresponding author. Tel.: +48 22 599 21 38; fax: +48 22 599 21 42. (Email: grzegorz.suwalski{at}wp.pl).

Objective: Antiplatelet therapy is a class I indication in perioperative care after coronary artery bypass grafting to prevent graft occlusion. We sought to determine whether continuation of aspirin until surgery day suppresses platelet activity in the early period after off-pump coronary artery bypass grafting (OPCAB). Material and methods: Forty-two patients at mean age of 62.5 (±7.9) years were included. Average risk rate (EuroScore logistic) was 2.2 (±1.7) %. In all patients collagen/epinephrine stimulated platelet plug formation (closure time, CT) (CEPI-CT, s) using a platelet function analyzer (PFA-100), troponin I (TnI), creatine kinase-MB (CK-MB), ST segment elevation were evaluated a day before surgery, 4 h after chest closure, 24 and 120 h after surgery. Results: Preoperative mean CEPI-CT was 224.8 (±79.7) s. In 13 (30%) patients aspirin resistance (CEPI-CT < 163 s.) was observed. In 4, 24 and 120 h time points CEPI-CT was significantly reduced: 164.4 (±79), 168.5 (±83.3) and 167.5 (±80.4), respectively (p < 0,001). TnI and CK-MB (ng/ml) levels raised in respective time points: 4 h (0.26 range 4; 1.9 range 6), 24 h (0.2 range 6; 2.6 range 8), 120 h (0.04 range 2; 0.6 range 5). ST segment elevation (mV) changed in time: 4 h (0.7 range 3.5), 48 h (0.7 range 2.8) and 120 h after surgery (0.2 range 1.5). There were no significant correlations between CEPI-CT and TnI, CK-MB, ST segment elevation found. Conclusion: Aspirin therapy continued until surgery day does not protect against acute platelet activation in patients after OPCAB.

Key Words: Off-pump revascularization • Platelet function • Aspirin







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.